Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares traded up 5.3% during mid-day trading on Wednesday . The stock traded as high as $39.20 and last traded at $39.20. 359 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 1,627 shares. The stock had previously closed at $37.21.
Hikma Pharmaceuticals Stock Up 5.3%
The company has a 50 day moving average of $35.34 and a 200-day moving average of $40.30.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
See Also
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
